Recombinant human parathyroid hormone

Recombinant human parathyroid hormone
Clinical data
Trade names	Preotact, Natpara
AHFS/Drugs.com	Monograph
MedlinePlus	a617013
License data	US DailyMed: Natpara;
Routes of; administration	Subcutaneous injection
ATC code	H05AA03 (WHO) ;
Legal status
Legal status	US: ℞-only ; In general: ℞ (Prescription only);
Identifiers
CAS Number	9002-64-6 ;
DrugBank	DB05829;
UNII	N19A0T0E5J;
KEGG	D05364;
Chemical and physical data
Formula	C408H674N126O126S2
Molar mass	9424.76 g·mol−1

Recombinant human parathyroid hormone, sold under the brand names Preotact and Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]

References

"FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Archived from the original on 30 January 2015. Retrieved 30 January 2015.
"Natpara Approval History". drugs.com. Retrieved 30 January 2015.

External links

"Parathyroid hormone". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". fda.gov. Archived from the original on 30 January 2015. Retrieved 30 January 2015.

[2] "Natpara Approval History". drugs.com. Retrieved 30 January 2015.